CNQ-T 0.25 GOOG-Q 4.39 TTNDY-OTC 0 NOG-N 0.56 DFH-N 0.61 APA-N 0.46 AP.UN-T 0.27
ISHARES DOW JONES US MEDICAL DEV.(ETF) (IHI-N)

ISHARES DOW JONES US MEDICAL DEV.(ETF) (IHI-N)

61 watching

NYSEARCA:IHI

61.90
1.19 (1.96%) 1d
May 27, 2025, 8:00 pm
0

Related posts

Nervous markets await Nvidia
BUY

ISHARES DOW JONES US MEDICAL DEV.(ETF)(IHI-N)

Aug 30, 2022
Allan Tong’s Discover Picks IHI's MER is actually higher (at 0.39%) than the yield it pays (0.3%). Like the other names here, IHI trades at a low beta, 0.86 to be precise. So, if you're not buying this for income, what's the growth? Let's look at IHI's largest holdings. TMO offers diversity among lab testing, lab equipment and diagnostics and typically trades at a premium multiple. TMO was a hit in the Covid-testing days, but that stereotype has stuck with them. The company reported a strong quarter a month ago, but that didn't move the needle. TMO shares have been choppy but rangebound all year, but if Wall Street gets gospel on TMO, share should pop. The price target is 20% higher at $674. Read 3 Best U.S. Healthcare ETFs for our full analysis.
Stockchase DiscoverStockchase Discover
Unknown
Unlock Rating
$50.540

Stock price when the opinion was issued

E.T.F.'s
BUY ON WEAKNESS

ISHARES DOW JONES US MEDICAL DEV.(ETF)(IHI-N)

Apr 04, 2022
Likes medical devices and health area as society ages. Would buy during a correcting. US and Europe have good healthcare stocks.
Larry Berman CFA, CMT, CTALarry Berman CFA, CMT, CTA
No
Unlock Rating
$61.105

Stock price when the opinion was issued

E.T.F.'s
BUY

ISHARES DOW JONES US MEDICAL DEV.(ETF)(IHI-N)

Aug 03, 2021

Happy to own this, outperforming XLV, for instance. It's diversified. ZUH is another option, because it covers pharmas, hospital management and other areas. IHI, as a hospital provider, is pretty good.

John HoodJohn Hood
Owned
Unlock Rating
$63.490

Stock price when the opinion was issued

E.T.F.'s
BUY

ISHARES DOW JONES US MEDICAL DEV.(ETF)(IHI-N)

Apr 22, 2021

Not overly bullish on healthcare as a whole, as its growth may be less attractive. Likes medical devices, with a built-in backlog due to Covid. He owns SYK. There should be a significant pickup in procedures over the next 2 years. SYK has strong earnings growth, near a 1-year high. Also look at IHI, the medical devices ETF, packed with companies leading the healthcare sector.

David BurrowsDavid Burrows
Unknown
Unlock Rating
$360.725

Stock price when the opinion was issued

E.T.F.'s
PARTIAL SELL

ISHARES DOW JONES US MEDICAL DEV.(ETF)(IHI-N)

Nov 03, 2020
This ETF has smashed it over the past 5 years. Medical devices are a hybrid of tech and healthcare, which he really likes. Problem is that market enthusiasm and growth are priced in here already (like the FAANGs). Take profits.
Tyler MordyTyler Mordy
Unknown
Unlock Rating
$307.020

Stock price when the opinion was issued

E.T.F.'s
BUY

ISHARES DOW JONES US MEDICAL DEV.(ETF)(IHI-N)

Apr 08, 2020
It specializes in medical devices and equipment. He has held this over a year and a half. He likes the diversification it offers. He is not sure which of the holdings are involved in manufacturing defibrillators.
John HoodJohn Hood
Owned
Unlock Rating
$239.735

Stock price when the opinion was issued

E.T.F.'s
DON'T BUY

ISHARES DOW JONES US MEDICAL DEV.(ETF)(IHI-N)

Feb 25, 2020
It's very nichy, though it offers good exposure to healthcare. It's a high-beta play on healthcare, biotech and medical devices. His main worry is uncertainty around the US election, namely Bernie Sanders. If he nationalizes medical care, then this ETF will suffer.
Tyler MordyTyler Mordy
Unknown
Unlock Rating
$256.900

Stock price when the opinion was issued

E.T.F.'s
BUY

ISHARES DOW JONES US MEDICAL DEV.(ETF)(IHI-N)

Dec 27, 2019
He likes medical devices a lot. The ETF looks good with reasonable MER. Once the rhetoric from the presidential campaign subsides, it’ll probably have more smooth sailing.
Richard CroftRichard Croft
No
Unlock Rating
$264.960

Stock price when the opinion was issued

E.T.F.'s
PAST TOP PICK

ISHARES DOW JONES US MEDICAL DEV.(ETF)(IHI-N)

Oct 03, 2019
(A Top Pick Oct 16/18, Up 16%) It continues to work. Everything is going right with this one. It is not a defensive name and while he likes it, he would not have more than a few percent of it in the market.
Cameron HurstCameron Hurst
No
Unlock Rating
$241.940

Stock price when the opinion was issued

E.T.F.'s
TOP PICK

ISHARES DOW JONES US MEDICAL DEV.(ETF)(IHI-N)

Oct 03, 2019
He loves it. It was flat over the last quarter. He is sticking with it.
Cameron HurstCameron Hurst
Owned
Unlock Rating
$241.940

Stock price when the opinion was issued

E.T.F.'s
PAST TOP PICK

ISHARES DOW JONES US MEDICAL DEV.(ETF)(IHI-N)

Sep 13, 2019

(A Top Pick Aug 15/18, Up 20%) A good way to play pharma without the litigation problems. For a Canadian one, it would be ZUH. Medical devices have done very well, and wish he had more.

John HoodJohn Hood
Owned
Unlock Rating
$248.790

Stock price when the opinion was issued

E.T.F.'s
TOP PICK

ISHARES DOW JONES US MEDICAL DEV.(ETF)(IHI-N)

Sep 11, 2019
A perennial favorite for him. Worldwide hospital spending, global spending and Type II diabetes on the rise all make this a good holding. It is fairly high beta, so if the market falls this will fall too. Yield 0.31%
Cameron HurstCameron Hurst
Owned
Unlock Rating
$248.420

Stock price when the opinion was issued

E.T.F.'s
TOP PICK

ISHARES DOW JONES US MEDICAL DEV.(ETF)(IHI-N)

Aug 07, 2019
The only area of healthcare he remains invested in. The demographics are creating tailwinds. An aging population and growing obesity is good for this. Good cash flow holdings and good diversification. Yield 0.32%
Cameron HurstCameron Hurst
Owned
Unlock Rating
$241.305

Stock price when the opinion was issued

E.T.F.'s
PAST TOP PICK

ISHARES DOW JONES US MEDICAL DEV.(ETF)(IHI-N)

Jul 10, 2019
(A Top Pick Jul 11/18, Up 19%) A great example of demographic and diabetes trends that has created huge growth in demand. A sad, but profitable story. Not a defensive stock and has beta with the market.
Cameron HurstCameron Hurst
Owned
Unlock Rating
$243.330

Stock price when the opinion was issued

E.T.F.'s
PAST TOP PICK

ISHARES DOW JONES US MEDICAL DEV.(ETF)(IHI-N)

Jun 05, 2019
(A Top Pick Jun 08/18, Up 11%) He continues to love holding this. Worldwide hospital spending continues to increase.
Cameron HurstCameron Hurst
Owned
Unlock Rating
$228.090

Stock price when the opinion was issued

E.T.F.'s
Showing 1 to 15 of 44 entries
Next PageNext Page

ISHARES DOW JONES US MEDICAL DEV.(ETF)(IHI-N) Rating

Ranking : 1 out of 5

Star iconStar empty iconStar empty iconStar empty iconStar empty icon

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for ISHARES DOW JONES US MEDICAL DEV.(ETF) is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

ISHARES DOW JONES US MEDICAL DEV.(ETF)(IHI-N) Frequently Asked Questions

What is ISHARES DOW JONES US MEDICAL DEV.(ETF) stock symbol?

ISHARES DOW JONES US MEDICAL DEV.(ETF) is a American stock, trading under the symbol IHI-N on the NYSE Arca (IHI). It is usually referred to as AMEX:IHI or IHI-N

Is ISHARES DOW JONES US MEDICAL DEV.(ETF) a buy or a sell?

In the last year, there was no coverage of ISHARES DOW JONES US MEDICAL DEV.(ETF) published on Stockchase.

Is ISHARES DOW JONES US MEDICAL DEV.(ETF) a good investment or a top pick?

ISHARES DOW JONES US MEDICAL DEV.(ETF) was recommended as a Top Pick by on . Read the latest stock experts ratings for ISHARES DOW JONES US MEDICAL DEV.(ETF).

Why is ISHARES DOW JONES US MEDICAL DEV.(ETF) stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is ISHARES DOW JONES US MEDICAL DEV.(ETF) worth watching?

0 stock analysts on Stockchase covered ISHARES DOW JONES US MEDICAL DEV.(ETF) In the last year. It is a trending stock that is worth watching.

What is ISHARES DOW JONES US MEDICAL DEV.(ETF) stock price?

On 2025-05-27, ISHARES DOW JONES US MEDICAL DEV.(ETF) (IHI-N) stock closed at a price of $61.9.

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

DIS-N 2.64$112.36
ATZ-T -0.52$66.48
MA-N 10.97$574.55
V-N 5.76$359.3
EA-Q 0.02$146.91

Today's Top Picks

CNQ-T 0.25$43.05
GOOG-Q 4.39$173.98
TTNDY-… 0$57.92
NOG-N 0.56$27.5
DFH-N 0.61$21.59

Popular Articles

Latest Sell Signals

VOD-Q 0.03$10.5
ARM-Q 6.78$133.96
BCE-T 0.27$29.67
IVN-T 0.52$11.29
HSBC-N -0.12$59.12

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Martin Cobb, ASIP

Martin Cobb, ASIP

Lorne Steinberg Wealth Management

Larry Berman CFA, CMT, CTA

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Derek Warren

Derek Warren

Lincluden Investment Mgmnt

Stockchase Insights

Stockchase Insights

5i Research

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: hello@stockchase.com.

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© Stockchase Inc. by Wealthica